Gyre Therapeutics Sees FY2026 Sales $100.500M-$111.000M vs $146.133M Est
Benzinga Newsdesk 7 months ago
NewsGuidance
Gyre Therapeutics (NASDAQ:GYRE) sees FY2026 sales of $100.500 million-$111.000 million vs $146.133 million analyst estimate.
Gyre Therapeutics (NASDAQ:GYRE) sees FY2026 sales of $100.500 million-$111.000 million vs $146.133 million analyst estimate.